Found: 7
Select item for more details and to access through your institution.
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07727-x
- By:
- Publication type:
- Article
Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7706, doi. 10.3390/ijms22147706
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01358-5
- By:
- Publication type:
- Article
TROP2 Expression in Sebaceous and Sweat Gland Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 607, doi. 10.3390/jcm11030607
- By:
- Publication type:
- Article
A case of tegafur/gimeracil/oteracil (TS-1)-induced acral hyperpigmentation: correlation between histopathological features and dermoscopic findings.
- Published in:
- Iranian Journal of Dermatology, 2023, v. 26, n. 4, p. 229, doi. 10.22034/ijd.2022.283963.1364
- By:
- Publication type:
- Article
TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 10, p. 1, doi. 10.1111/exd.15196
- By:
- Publication type:
- Article
NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 3, p. 1, doi. 10.1111/exd.15049
- By:
- Publication type:
- Article